Endo Launches Innovative Spatial Computing Injection Simulator
MALVERN, Pa., March 26, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today the launch of a first-of-its-kind initiative for a pharmaceutical company: the Spatial Computing Injection Simulator. The simulator leverages the power of spatial computing (also called "mixed reality") to augment a fully immersive learning environment for healthcare providers on Apple Vision Pro.
The Spatial Computing Injection Simulator allows hand specialists to interact simultaneously with both physical and digital objects—blending a physical hand model and digital content via an Apple Vision Pro app—to help refine their injection technique. All members of Endo's orthopedics sales team are able to offer the experience to healthcare providers.
Experience the Interactive Multimedia News Release
Click here to explore the experience.
"The Spatial Computing Injection Simulator represents a major leap forward in enhancing patient care through a groundbreaking educational tool," said Justin Mattice, Senior Vice President & General Manager, Branded Specialty at Endo.
Endo designed the Spatial Computing Injection Simulator to help hand specialists refine their injection technique in the hand for the administration of XIAFLEX® (collagenase clostridium histolyticum), the only FDA-approved nonsurgical treatment for Dupuytren's contracture when a "cord" can be felt.
Important Safety Information for XIAFLEX
Do not receive XIAFLEX if you have had an allergic reaction to collagenase clostridium histolyticum or any of the ingredients in XIAFLEX, or to any other collagenase product.
The Experience
The Spatial Computing Injection Simulator allows providers to interact with both physical objects and digital content simultaneously via a lifelike hand simulator model and an Apple Vision Pro app.
During the immersive, 20-minute experience, hand specialists receive "hands-on" practice on reconstitution and injection angles, watch procedures in action, practice their injection technique on the hand model, and acquire information on the post-injection process.
Early Reactions and Reviews
Endo recently previewed the technology at two premier medical conferences and generated interest and buzz for the program. At both the American Society for Surgery of the Hand (ASSH) and American Association for Hand Surgery (AAHS) annual meetings, healthcare providers lined up to try on the headsets and test their injection technique. In total, more than 600 hand specialists used the Spatial Computing Injection Simulator during the previews.
"Technology like this can make a huge difference for a hand surgeon or advanced practice provider in treating Dupuytren's contracture nonsurgically," said Dr. Jason Fanuele, an orthopedic surgeon who specializes in hand and upper extremity.
About Dupuytren's Contracture
Dupuytren's contracture is a lifelong condition that may get worse over time. It's caused by a buildup of collagen in the hand, which forms a rope-like cord that pulls fingers toward the palm so they can't be straightened. As Dupuytren's contracture progresses, it may become difficult for individuals to use their hand(s) for daily tasks and activities. Dupuytren's contracture affects an estimated 17 million Americans.
About Endo
Endo is a diversified specialty pharmaceutical company boldly transforming insights into life-enhancing therapies. Our passionate team members collaborate to develop and deliver these essential medicines. Together, we are committed to helping everyone we serve live their best life. Learn more at www.endo.com or connect with us on LinkedIn.
